Michael Miller

38.8k total citations · 10 hit papers
435 papers, 21.5k citations indexed

About

Michael Miller is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Miller has authored 435 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Surgery, 97 papers in Endocrinology, Diabetes and Metabolism and 88 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Miller's work include Lipoproteins and Cardiovascular Health (83 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (81 papers) and Reconstructive Surgery and Microvascular Techniques (62 papers). Michael Miller is often cited by papers focused on Lipoproteins and Cardiovascular Health (83 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (81 papers) and Reconstructive Surgery and Microvascular Techniques (62 papers). Michael Miller collaborates with scholars based in United States, Canada and France. Michael Miller's co-authors include Christie M. Ballantyne, Terry A. Jacobson, Eliot A. Brinton, Deepak L. Bhatt, Stephen S. Kroll, Mark A. Schusterman, Penny M. Kris‐Etherton, Gregory P. Reece, Philippe Gabríel Steg and Jean‐Claude Tardif and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Miller

420 papers receiving 20.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

2018 2.0k citations Deepak L. Bhatt, Philippe Gabríel Steg et al. profile →
Triglycerides and Cardiovascular Disease

2011 1.4k citations Michael Miller, Neil J. Stone et al. Circulation profile →
Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association

2017 908 citations Frank M. Sacks, Alice H. Lichtenstein et al. Circulation profile →
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion

1993 569 citations Michael Miller et al. profile →
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

2008 517 citations Toni I. Pollin, Coleen Damcott et al. Science profile →
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

2019 488 citations Terry A. Jacobson, Michael Miller et al. profile →
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

2008 448 citations Michael Miller et al. profile →
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

2019 331 citations Eliot A. Brinton, Penny M. Kris‐Etherton et al. Circulation profile →
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis

2021 222 citations Roger S. Blumenthal, Khurram Nasir et al. profile →
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia

2021 167 citations Christie M. Ballantyne, Penny M. Kris‐Etherton et al. profile →

Peers

Countries citing papers authored by Michael Miller

Since Specialization

Citations

This map shows the geographic impact of Michael Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Miller more than expected).

Fields of papers citing papers by Michael Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Miller. The network helps show where Michael Miller may publish in the future.

Co-authorship network of co-authors of Michael Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Miller. A scholar is included among the top collaborators of Michael Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Miller. Michael Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America 2024 ·Journal of clinical lipidology ·Robert A. Hegele, Zahid Ahmad, Ambika P. Ashraf, (unknown), Alan S. Brown, Alan Chait, Steven D. Freedman, Brenda Kohn, Michael Miller, Nivedita Patni, Daniel Soffer, Jian Wang, Michael S. Broder, Eunice Chang, Irina Yermilov, Cynthia Campos, Sarah N. Gibbs	16
2	The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial 2023 ·Nature Medicine ·Deepak L. Bhatt, Harold Bays, Michael Miller, (unknown), Katarzyna Wasilewska, Nabil Andrawis, Teresa Parli, Shibao Feng, Lulu Ren Sterling, Leo Tseng, Cynthia L. Hartsfield, Germaine D. Agollah, Hank Mansbach, John J.P. Kastelein, (unknown)	66
3	Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT 2023 ·Journal of the American Heart Association ·Brian Olshansky, Deepak L. Bhatt, Michael Miller, Philippe Gabríel Steg, Eliot A. Brinton, Terry A. Jacobson, (unknown), Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Peter R. Kowey, James A. Reiffel, Jean‐Claude Tardif, Christie M. Ballantyne, Mina K. Chung, (unknown)	17
4	Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy 2022 ·Circulation ·Paul M. Ridker, Nader Rifai, Jean MacFadyen, Robert J. Glynn, Lixia Jiao, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Jean‐Claude Tardif, Christie M. Ballantyne, R. Preston Mason, Deepak L. Bhatt	80
5	Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA 2021 ·Journal of the American Heart Association ·Karan Kapoor, Abdulhamied Alfaddagh, Mahmoud Al Rifai, Deepak L. Bhatt, Matthew J. Budoff, Khurram Nasir, Michael Miller, Francine K. Welty, John W. McEvoy, Zeina Dardari, Michael D. Shapiro, Roger S. Blumenthal, Michael Y. Tsai, Michael J. Blaha	14
6	Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder 2021 ·SHILAP Revista de lepidopterología ·Teodor T. Postolache, Deborah R. Medoff, Clayton H. Brown, Li Fang, (unknown), Christopher A. Lowry, Michael Miller, Julie Kreyenbuhl	7
7	Benefits of Icosapent Ethyl Across a Range of Baseline Renal Function in Patients with Established Cardiovascular Disease or Diabetes: Results of REDUCE-IT RENAL 2020 ·Journal of the American Society of Nephrology ·Arjun Majithia, Deepak L. Bhatt, Allon N. Friedman, Michael Miller, Philippe Gabríel Steg, Eliot A. Brinton, Terry A. Jacobson, (unknown), Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, Matthew J. Budoff, (unknown), Jean‐Claude Tardif, William E. Boden, Christie M. Ballantyne, (unknown)	2
8	Vasculogenic Erectile Dysfunction: The Impact of Diet and Lifestyle 2020 ·The American Journal of Medicine ·Robert J. Ostfeld, Kathleen Allen, Karen Aspry, Eric Brandt, Aaron Spitz, Joshua Liberman, (unknown), James H. O’Keefe, Monica Aggarwal, Michael Miller, (unknown), Stephen L. Kopecky, Beth White, (unknown), (unknown), (unknown), Ron Blankstein, Koushik Reddy, Dean Ornish, Andrew M. Freeman	27
9	Science dialogue mapping of knowledge and knowledge gaps related to the effects of dairy intake on human cardiovascular health and disease 2020 ·Critical Reviews in Food Science and Nutrition ·Andrew W. Brown, Kathryn A. Kaiser, (unknown), Kevin R. Fontaine, (unknown), Barbara A. Gower, James M. Shikany, Colby J. Vorland, Donald C. Beitz, Dennis M. Bier, J. Thomas Brenna, David R. Jacobs, Penny M. Kris‐Etherton, Kevin C. Maki, Michael Miller, Marie‐Pierre St‐Onge, Margarita Terán‐García, David B. Allison	17
10	Video Discharge Instructions for Acute Otitis Media in Children: A Randomized Controlled Open‐label Trial 2019 ·Academic Emergency Medicine ·(unknown), (unknown), (unknown), Samina Ali, (unknown), (unknown), (unknown), Michael Miller, (unknown), Naveen Poonai	6
11	Development of a clinical risk score to predict resistance to intravenous immunoglobulin in children with Kawasaki Disease 2019 ·PEDIATRICS ·(unknown), (unknown), Michael Miller	1
12	Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association breakdown → 2017 ·Circulation ·Frank M. Sacks, Alice H. Lichtenstein, Jason Wu, Lawrence J. Appel, Mark A. Creager, Penny M. Kris‐Etherton, Michael Miller, Eric B. Rimm, Lawrence L. Rudel, Jennifer G. Robinson, Neil J. Stone, Linda Van Horn	908
13	Vitamin and Supplement Use among Old Order Amish: Sex-Specific Prevalence and Associations with Use 2014 ·Journal of the Academy of Nutrition and Dietetics ·Robert M. Reed, (unknown), Patrick F. McArdle, Michael Miller, Toni I. Pollin, Alan R. Shuldiner, Nanette Steinle, Braxton D. Mitchell	10
14	A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection breakdown → 2008 ·Science ·Toni I. Pollin, Coleen Damcott, Haiqing Shen, Sandra Ott, John C. Shelton, Richard B. Horenstein, Wendy S. Post, John C. McLenithan, Lawrence F. Bielak, Patricia A. Peyser, Braxton D. Mitchell, Michael Miller, Jeffrey R. O’Connell, Alan R. Shuldiner	517
15	Optimizing Autologous Breast Reconstruction in Thin Patients 2003 ·Plastic & Reconstructive Surgery ·Steven J. Kronowitz, Geoffrey L. Robb, Adel Youssef, Gregory P. Reece, Shih-Hsin Chang, Cynthia A. Koutz, Roy Ng, Joan E. Lipa, Michael Miller	34
16	Genetics of HDL regulation in humans 2003 ·Current Opinion in Lipidology ·Michael Miller, Jeffrey Rhyne, (unknown), J Birnbaum, (unknown)	53
17	An interactive CD-ROM for nutrition screening and counseling 2000 ·American Journal of Public Health ·Gladys Block, Michael Miller, Lisa Harnack, (unknown), (unknown), (unknown)	27
18	Un registro de 6 000 años de manifestaciones intensas del fenómeno de El Niño en sedimentos de lagunas de las islas Galápagos 1998 ·Digital Commons - University of South Florida (University of South Florida) ·Miriam Steinitz‐Kannan, (unknown), (unknown), (unknown), Michael Miller	1
19	Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Schumacher Hr, (unknown), Akira Sagawa, Jean‐Louis Hébert, Esaú Fernández‐Pascual, (unknown), Michael Miller, (unknown), (unknown)	20
20	Branchial Anomalies in Idiopathic Hypoparathyroidism: Branchial Dysembryogenesis 1972 ·Michael Miller, Boy Frame, Andrew K. Poznanski, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact